Preoperative Evaluation of the Remaining Part of the Liver for Liver Resection

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-10-01

Study Completion Date

2022-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

* Review the outcomes of the current treatments modalities.
* Give an effective treatment .
* Improve the outcome of these patients and decease rate of recurrence and complications.
* An adequate future liver remnant (FLR) reduces the risk of postoperative liver failure after major hepatectomy.
* incurs a risk of postoperative liver dysfunction and infection and there is a lack of objective evidence relating residual liver volume to these complications

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Complicated Outcome Prediction After Liver Resection

NCT03577067

Liver Neoplasms

COMPLETED

Quality of Life After Liver Resection

NCT00681499

Liver Diseases Liver Neoplasms

COMPLETED

Hepatectomy Risk Assessment With Functional Magnetic Resonance Imaging

NCT04705194

Hepatectomy Liver Failure Liver Cancer +1 more

UNKNOWN

Preoperative Edema is a Significant Risk Factor for Post-hepatectomy Complications

NCT06555510

Patients Who Underwent Hepatectomy for Liver Neoplasms

COMPLETED

Laparoscopic Liver Resection

NCT00553033

Tumors

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A liver resection is the surgical removal of all or a portion of the liver. It is also referred to as a hepatectomy, full or partial. A complete liver resection is performed in the setting of a transplant a diseased liver is removed from a deceased donor (cadaver). A living donor may also provide a piece of liver tissue which is procured through a partial hepatectomy, The procedure may be performed through a traditional open procedure or using minimally invasive techniques.

When is Liver Resection Performed Most hepatectomies are performed for the treatment of hepatic neoplasms, both benign or malignant. Benign neoplasms include hepatocellular adenoma, hepatic hemangioma and focal nodular hyperplasia.The most common malignant neoplasms (cancers) of the liver are metastases; those arising from colorectal cancer are among the most common, and the most amenable to surgical resection. The most common primary malignant tumour of the liver is the hepatocellular carcinoma. Hepatectomy may also be the procedure of choice to treat intrahepatic gallstones or parasitic cysts of the liver.

Liver surgery is safe when performed by experienced surgeons with appropriate technological and institutional support. As with most major surgical procedures, there is a marked tendency towards optimal results at the hands of surgeons with high caseloads in selected centres (typically cancer academic medical centers and transplantation centers).

Partial hepatectomy is surgery to remove part of the liver. Only people with good liver function who are healthy enough for surgery and who have a single tumor that has not grown into blood vessels can have this operation.

Imaging tests, such as CT or MRI with angiography are done first to see if the cancer can be removed completely. Still, sometimes during surgery the cancer is found to be too large or has spread too far to be removed, and the surgery that has been planned cannot be done.

Can a portion of the remaining normal liver grow back? When a portion of a normal liver is removed, the remaining liver can grow back (regenerate) to the original size within several weeks. A cirrhotic liver, however, cannot grow back. Therefore, before resection is performed for HCC, the non-tumor portion of the liver should be biopsied to determine whether there is associated cirrhosis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Liver Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patient under going liver resection

Group Type OTHER

resection

Intervention Type DIAGNOSTIC_TEST

CT volumetry,liver function,biopsy before resection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

resection

CT volumetry,liver function,biopsy before resection

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients undergoing liver resection for benign or malignant hepatic neoplasm at the time of study(two years)
* Patient consent.
* Age of the patient : Any age

Exclusion Criteria

* patients has contraindication to do liver resection surgery.
* patients who are unfit for any surgical interventions.
* patients who refuse the operation or refusing to share his data.

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes